alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<CIK>                         0000748901
<NAME>                                             PS PARTNERS IV, LTD.
<MULTIPLIER>                                                          1
<CURRENCY>                                                       U.S. $
       
<S>                                                                 <C>
<PERIOD-TYPE>                                                     3-MOS
<FISCAL-YEAR-END>                                           DEC-31-1997
<PERIOD-START>                                               JAN-1-1997
<PERIOD-END>                                                MAR-31-1997
<EXCHANGE-RATE>                                                       1
<CASH>                                                          561,000
<SECURITIES>                                                          0
<RECEIVABLES>                                                    61,000
<ALLOWANCES>                                                          0
<INVENTORY>                                                           0
<CURRENT-ASSETS>                                                622,000
<PP&E>                                                       59,828,000
<DEPRECIATION>                                             (20,757,000)
<TOTAL-ASSETS>                                               59,593,000
<CURRENT-LIABILITIES>                                         1,064,000
<BONDS>                                                               0
<PREFERRED-MANDATORY>                                                 0
<PREFERRED>                                                           0
<COMMON>                                                              0
<OTHER-SE>                                                   19,690,000
<TOTAL-LIABILITY-AND-EQUITY>                                 59,593,000
<SALES>                                                               0
<TOTAL-REVENUES>                                              3,048,000
<CGS>                                                                 0
<TOTAL-COSTS>                                                 1,191,000
<OTHER-EXPENSES>                                                563,000
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                    0
<INCOME-PRETAX>                                                 420,000
<INCOME-TAX>                                                          0
<INCOME-CONTINUING>                                             420,000
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                    420,000
<EPS-PRIMARY>                                                      2.86
<EPS-DILUTED>                                                      2.86
        

</TABLE>
Janet CAHANIN v. LOUISIANA MEDICAL MUTUAL INSURANCE COMPANY, Ludwig C. Heintz, M.D. and Julie A. Lawrence, M.D.

NO. 2018-C-0129

Supreme Court of Louisiana.

March 9, 2018

Denied.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted
from Sterling Drilling Fund 1984-1 Third Quarter 1996 10-Q and
is qualified in its entirety by reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               SEP-30-1996
<CASH>                                          14,693
<SECURITIES>                                         0
<RECEIVABLES>                                    1,800
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                16,493
<PP&E>                                       7,901,810
<DEPRECIATION>                              (6,892,027)
<TOTAL-ASSETS>                               1,026,276
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,026,276<F1>
<TOTAL-LIABILITY-AND-EQUITY>                 1,026,276
<SALES>                                        176,605<F2>
<TOTAL-REVENUES>                               176,605
<CGS>                                          181,479
<TOTAL-COSTS>                                  181,479
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (4,874)
<EPS-PRIMARY>                                    (1.02)<F3>
<EPS-DILUTED>                                        0
<FN>
<F1>Other - se includes total partners' equity.
<F2>Sales includes $268 of interest income.
<F3>The limited partnership net income was divided by the total
number of limited partnership units od 9,236.
</FN>
        

</TABLE>
|   | 1. | Such Annual Report on Form 10-K      for the year ending March 31, 2009 fully      complies with the requirements of section 13(a) or 15(d) of the Securities      Exchange Act of 1934; and |
|--------|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   |   |                                                                                                                                                                                                                             |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | 2.     | The information contained in such      Annual Report on Form 10-K for the fiscal year ended March 31, 2009 fairly      presents, in all material respects, the financial condition and results of      operations of theCompany. |

| /s/ Jack Jie      Qin                                |
|------------------------------------------------------|
| Jack Jie  Qin                                        |
| Chief Executive Officer, President      and Chairman |
| (Principal Executive      Officer)                   |

----
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Medical Action Industries Inc. (the
Company) for the quarter ended June 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Paul D. Meringolo, Chief Executive Officer, Chairman of the Board and
President of the Company, certifies, to the best knowledge and belief of the signatory, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                                                            
|------------------------------------------------------------
|/s/ Paul D. Meringolo                                       
|Chief Executive Officer, Chairman of the Board and President

Date: August 8, 2008



30
| Australia                                                                                                       | Mission NewEnergy LimitedHead Office Unit B9, 431 RobertsRd, Subiaco, Western Australia, 6008, Australia.  |                                                                                             |
|----------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------|
| Malaysia                                                                                                        | Mission Biofuels Sdn BhdNo 5ENadayu 28 DagangJalanPJS 11/7BandarSunway47500Subang JayaSelangor,Malaysia         | M2Capital Sdn BhdNo 5ENadayu 28 DagangJalanPJS 11/7BandarSunway47500Subang JayaSelangor,Malaysia |
|   FGV Green Energy Sdn BhdLevel45, Menara Felda, Platinum ParkNo. 11,Persiaran KLCC50088Kuala Lumpur  |                                                                                                            |
|                                                                                                                 |                                                                                                            |
Exhibit 32.2

Certification of the Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of NPC International, Inc. (the Company) on Form 10-Q for the period ended June 29, 2010 as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, Troy D. Cook, Executive Vice-President - Finance, Chief Financial Officer, Secretary and Treasurer of NPC International, Inc., certify, pursuant to 18
U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------

Date: August 6, 2010



/s/ Troy D. CookTroy D. Cook
Executive Vice PresidentFinance,
Chief Financial Officer, Secretary and Treasurer
[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Page 2804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00818]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Office for Civil Rights; Statement of Delegation

    Notice is hereby given that I have delegated to the Director of the 
Office for Civil Rights, or his or her successor, the authorities 
vested in the Secretary concerning enforcement of and compliance with 
Section 1303(b)(4) of the Patient Protection and Affordable Care Act, 
42 U.S.C. 18023(b)(4). This delegation transfers, but only for the 
authorities pursuant to Section 1303(b)(4) and not for other 
authorities under Section 1303, the previous delegation to the 
Administrator, Centers for Medicare & Medicaid Services, or his or her 
successor, noticed at 76 FR 53903 (Aug. 30, 2011).
    Pursuant to this delegation, the OCR Director shall have the 
authority to:
    (1) Accept and investigate complaints filed by individuals or 
entities alleging a failure to comply with Section 1303(b)(4);
    (2) conduct Section 1303(b)(4) compliance reviews;
    (3) provide technical assistance to departmental components and 
qualified health plans regarding Section 1303(b)(4) compliance;
    (4) evaluate the effectiveness of subsection 1303(b)(4) complaint 
processing by OCR and provide reports to appropriate oversight 
organizations; and
    (5) initiate such other actions as may be necessary to facilitate 
and ensure compliance with Section 1303(b)(4).
    This authority may be redelegated. If the OCR Director chooses to 
redelegate this authority, the OCR Director will maintain primary 
responsibility and accountability for implementation of this section. 
This delegation is effective upon date of signature. I hereby affirm 
and ratify any actions taken by the Director of OCR or subordinates 
which involved the exercise of the authorities delegated herein prior 
to the effective day of this delegation.

    Dated: December 7, 2017.
Eric D. Hargan,
Acting Secretary, Department of Health and Human Services.
[FR Doc. 2018-00818 Filed 1-18-18; 8:45 am]
 BILLING CODE 4153-01-P
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 01-7682

AVON M. NEAL, JR.,

Plaintiff - Appellant,

versus

FORMER SUPERINTENDENT SMILEY; MR. EVANS,

Assistant Superintendent,

Defendants - Appellees.

Appeal from the United States District Court for the Eastern

District of North Carolina, at Raleigh. W. Earl Britt, Senior

District Judge. (CA-01-506-5-2BR)

Submitted: April 18, 2002 Decided: April 25, 2002

Before MOTZ, TRAXLER, and GREGORY, Circuit Judges.

Affirmed by unpublished per curiam opinion.

Avon M. Neal, Jr., Appellant Pro Se.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Avon M. Neal, Jr., appeals the district court’s order denying

relief on his 42 U.S.C.A. § 1983 (West Supp. 2001) complaint. We

have reviewed the record and the district court’s opinion and find

no reversible error. Accordingly, we affirm on the reasoning of the

district court. See Neal v. Smiley, No. CA-01-506-5-2BR (E.D.N.C.

filed Aug. 22, 2001, entered Aug. 23, 2001). We dispense with oral

argument because the facts and legal contentions are adequately

presented in the materials before the court and argument would not

aid the decisional process.

AFFIRMED
The State of TexasAppellee/s



# Fourth Court of Appeals

**San Antonio, Texas**

April 15, 2014

N o. 04

- 13

- 00238

- CR

Ricardo PEDRAZA

, Appellant

v.

THE STATE OF TEXAS,

A ppellee

From the 49th Judicial District Court, Webb County, Texas

Trial Court No. 2012CRR107

- D1

Honorable Jose A. Lopez, Judge Presiding



### ORDER

The Appellant ’ s Motion for Extension of Time to File Brief filed on December 20, 2013

is hereby MOOT.

_________________________________ Rebeca C. Martinez, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 15th day of April, 2014

.

___________________________________ Keith E. Hottle

Clerk of Court
Date: July 12, 2012 To: Terri Plumb

Regulations Development Group OSORA From: Anne E. Tayl oe Hauswald

Director Division of Ambulatory

Services (C enter for Medicare/HAPG ) Subject: Rulemaking Record for CMS - 15 90 - P: Medi care Program; Pay ment Policies under the Ph ys ician Fee Schedule , DME Face - to - Face Encounters, Elimination of the Requirement for Termination of Non - random Prepay ment Complex Medical Review, and Other Revisions to Part B for CY 2013 I certify that t o the best of my

knowledge , the attached informati on includes all material that the Division of Ambulatory Services (CM/HAPG ) considered , or had before it in developing the above - referenced rul e. I have identified any proprietary data or confidential information that should not be released to the public upon a request for information under the Freedom of Information Act (FOIA). Attached is an index of all material included .**Index of Supporting Information for:** 

CMS - 15 90 - P: Medi care Program; Pay ment Policies under the Ph ys ician Fee Schedule , DME Face - to - Face Encounters, Elimination of the Requirement for Termination of Non random Prepay

ment Complex Medical Review, and Other Revisions to Part B for

CY 2013 Title of Document Does this document contain confidential information or p roprietary data? 1. CR7397 - R2368CP.pdf No 2. CR71009 - R2115CP.pdf No 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13.
EXHIBIT  99.1

                 CERTIFICATE PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and in connection
with  the  Quarterly Report on Form 10-Q of Concurrent Computer Corporation (the
"Corporation")  for  the  quarter  ended  September  30, 2002, as filed with the
Securities  and  Exchange  Commission  on  the  date  hereof (the "Report"), the
undersigned,  the  President  and  Chief  Executive  Officer  of the Corporation
certifies  that:

     (1)  The  Report  fully  complies with the requirements of Section 13(a) or
          15(d)  of  the  Securities  Exchange  Act  of  1934;  and

     (2)  The  information  contained  in  the  Report  fairly  presents, in all
          material respects, the financial condition and results of operation of
          the  Corporation.


  /s/ Jack A. Bryant
-------------------------------
Jack A. Bryant
President and Chief Executive Officer
November 13, 2002


                                      -24-
<PAGE>
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Biotel Inc. (the Company) on Form 10-KSB for the year ended June 30, 2007, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, in the capacities listed below, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  (i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





Dated: September 26, 2007
        
        
        /s/   B. Steven SpringroseB. Steven SpringroseChief Executive Officer (principal executive officer)






Dated: September 26, 2007
        
        
        /s/   Judy E. NausJudy E. NausChief Financial Officer(principal financial officer)






A signed original of this written statement required by Section 906 has been provided to Biotel Inc. and will be retained by Biotel Inc. and furnished to the Securities and Exchange Commission or its staff upon request.









---
700 Louisiana Suite 1700 Houston, TX 77002 +1 713 546 5000 tel +1 713 224 9511 fax

WEIL:\95570402\1\99995.5434 December 18, 2015 Alfredo R Pérez +1 (713) 546-5040 alfredo.perez@weil.com

Abel Acosta Court of Criminal Appeals Supreme Court Building 201 West 14th Street, Room 106 Austin, Texas 78701

Re: The State of Texas v. Larry Ray Swearingen, No. AP-77,043

Dear Mr. Acosta:

We write to inform you that we represent Jennifer L. Smith, M.S. On behalf of Ms. Smith, we submit this letter in support of and to join the amicus curiae brief filed with this Court in the above-captioned action on December 16, 2015.

Jennifer L. Smith, M.S., is a Senior Forensic Analyst at the UNT Health Science Center’s Center for Human Identification. She is qualified or has testified as an expert in Serology and/or DNA analysis in Texas, California, Georgia, Illinois, Maryland, Massachusetts, New York, North Carolina, Ohio, Tennessee, and Virginia. Prior to joining UNT’s Health Science Center, she worked for seven years at Cellmark Forensics (formerly Orchid Cellmark Inc.) in Dallas, Texas, ending with the position of Senior Forensic DNA Analyst. Her primary focus at Cellmark Forensics was the examination and analysis of post-conviction and cold cases, and her work included accessioning and conducting serological examinations on forensic evidence for subsequent DNA analysis, conducting PCR analysis of forensic casework, interpreting data, generating reports, providing expert testimony, and training new personnel in accessioning, evidence handling, and serological techniques. Between 1998 and 2008, Ms. Smith worked at the Virginia Division of Forensic Science. Ms. Smith has a B.S. in Biology from Cameron University and an M.S. in Criminal Justice with a Specialization in Forensic Science from Virginia Commonweath University.

Respectfully submitted,

/s/ Alfredo R Pérez

Alfredo R Pérez

cc: all counsel AP-77,043 COURT OF CRIMINAL APPEALS

AUSTIN, TEXAS Transmitted 12/18/2015 11:29:18 AM Accepted 12/18/2015 11:38:21 AM

ABEL ACOSTA CLERK
Kevin Lyman BROWN, Appellant, v. STATE of Florida, Appellee.

No. 4D14-4231

District Court of Appeal of Florida, Fourth District.

[December 21, 2017]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.